Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Accel. buyback
Quarterly results
Auditor change
AbbVie Inc. (ABBV) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 Alpern Robert J (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 50 options to buy @ $149.06, valued at $7.5k
10/03/2023 4 RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 259 options to buy @ $149.06, valued at $38.6k
09/27/2023 4 GONZALEZ RICHARD A (CHAIRMAN OF THE BOARD AND CEO) has filed a Form 4 on AbbVie Inc.
Txns: Gifted 42,000 shares @ $0
08/02/2023 4 GONZALEZ RICHARD A (CHAIRMAN OF THE BOARD AND CEO) has filed a Form 4 on AbbVie Inc.
Txns: Sold 18,500 shares @ $149.15, valued at $2.8M
Sold 60,000 shares @ $148.58, valued at $8.9M
07/10/2023 3 Donoghoe Nicholas (EVP, Chief Bus/Strat Officer) has filed a Form 3 on AbbVie Inc.
07/05/2023 4 RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 287 options to buy @ $134.73, valued at $38.7k
07/05/2023 4 Alpern Robert J (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 55 options to buy @ $134.73, valued at $7.4k
05/12/2023 4 Strom Carrie C (SVP & PRES GLOBAL ALLERG AESTH) has filed a Form 4 on AbbVie Inc.
Txns: Paid exercise price by delivering 2,876 shares @ $146.42, valued at $421.1k
05/09/2023 4 WADDELL FREDERICK H (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 1,450 shares @ $0
05/09/2023 4 TILTON GLENN F (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 1,450 shares @ $0
05/09/2023 4 Roberts Rebecca B (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 1,450 shares @ $0
05/09/2023 4 RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 1,450 shares @ $0
05/09/2023 4 MEYER MELODY B (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 1,450 shares @ $0
05/09/2023 4 Hart Brett J (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 1,450 shares @ $0
05/09/2023 4 AUSTIN ROXANNE S (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 1,450 shares @ $0
05/09/2023 4/A AUSTIN ROXANNE S (Director) has filed a Form 4 on AbbVie Inc.
Txns: Sold 6,222 shares @ $150.5, valued at $936.4k
05/09/2023 4 BURNSIDE WILLIAM H.L. (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 1,450 shares @ $0
05/09/2023 4 FREYMAN THOMAS C (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 1,450 shares @ $0
05/09/2023 4 Alpern Robert J (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 1,450 shares @ $0
05/02/2023 4 TILTON GLENN F (Director) has filed a Form 4 on AbbVie Inc.
Txns: Exercised 2,230 options to buy @ $151.12, valued at $337k
04/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2023 4 Sorg Elaine K. (SVP, US COMMERCIAL OPERATIONS) has filed a Form 4 on AbbVie Inc.
Txns: Sold 15,002 shares @ $160.03, valued at $2.4M
Exercised 15,002 options to buy @ $93.5, valued at $1.4M
04/05/2023 4 Siatis Perry C (EVP, GC AND SECRETARY) has filed a Form 4 on AbbVie Inc.
Txns: Sold 3,520 shares @ $160, valued at $563.2k
Exercised 3,520 options to buy @ $105.92, valued at $372.8k
04/04/2023 4 Alpern Robert J (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 47 options to buy @ $159.37, valued at $7.5k
04/04/2023 4 RAPP EDWARD J (Director) has filed a Form 4 on AbbVie Inc.
Txns: Granted 243 options to buy @ $159.37, valued at $38.7k
03/15/2023 4 Stewart Jeffrey Ryan (EVP, CHIEF COMMERCIAL OFFICER) has filed a Form 4 on AbbVie Inc.
Txns: Sold 21,810 shares @ $152.3, valued at $3.3M
Sold 31,315 shares @ $152.27, valued at $4.8M
Exercised 21,810 options to buy @ $54.86, valued at $1.2M
03/10/2023 3 Buckbee Kevin K (SVP, Controller) has filed a Form 3 on AbbVie Inc.
03/07/2023 4 GONZALEZ RICHARD A (CHAIRMAN OF THE BOARD AND CEO) has filed a Form 4 on AbbVie Inc.
Txns: Gifted 2,550 shares @ $0
03/07/2023 4 Strom Carrie C (SVP & PRES GLOBAL ALLERG AESTH) has filed a Form 4 on AbbVie Inc.
Txns: Paid exercise price by delivering 449 shares @ $156.06, valued at $70.1k
03/02/2023 4 Strom Carrie C (SVP & PRES GLOBAL ALLERG AESTH) has filed a Form 4 on AbbVie Inc.
Txns: Paid exercise price by delivering 5,762 shares @ $154.28, valued at $889k
Paid exercise price by delivering 810 shares @ $155.27, valued at $125.8k
03/02/2023 4 Sorg Elaine K. (SVP, US COMMERCIAL OPERATIONS) has filed a Form 4 on AbbVie Inc.
Txns: Paid exercise price by delivering 19,850 shares @ $154.28, valued at $3.1M
Sold 15,003 shares @ $155, valued at $2.3M
Exercised 15,003 options to buy @ $93.5, valued at $1.4M
03/02/2023 4 Siatis Perry C (EVP, GC AND SECRETARY) has filed a Form 4 on AbbVie Inc.
Txns: Paid exercise price by delivering 9,656 shares @ $154.28, valued at $1.5M
Sold 11,330 shares @ $153.06, valued at $1.7M
Sold 805 shares @ $153.38, valued at $123.5k
03/02/2023 4 Reents Scott T (EVP, CFO) has filed a Form 4 on AbbVie Inc.
Txns: Paid exercise price by delivering 12,683 shares @ $154.28, valued at $2M
Sold 15,092 shares @ $153.06, valued at $2.3M
Sold 850 shares @ $153.38, valued at $130.4k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy